日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

P-2194. Prevalence of Hepatitis B and Hepatitis A in People with Chronic Active Hepatitis C in New Jersey

P-2194. 新泽西州慢性活动性丙型肝炎患者中乙型肝炎和甲型肝炎的患病率

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines8010014
Petrini, Stefano; Righi, Cecilia; Iscaro, Carmen; Viola, Giulio; Gobbi, Paola; Scoccia, Eleonora; Rossi, Elisabetta; Pellegrini, Claudia; De Mia, Gian Mario; Slim, Jihad; Akiki, Maria; Tempalski, Barbara; Rosmarin-DeStefano, Corey; Torres, Juan; Leyden, Kevin; Duprey, Sheena; Levaggi, Emily
肝炎
发表日期：2025
文献求助 收藏

Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment

财务毒性问卷（FIT）：在接受多模式根治性治疗的头颈癌患者中开发和验证意大利语版本（FITALY）

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-13230-5
Smussi, Davide; Conti, Carlo; Lorini, Luigi; Mattavelli, Davide; Levaggi, Rosella; Miniaci, Raffaele; Calza, Stefano; Deganello, Alberto; Paduano, Consiglia; Alberti, Andrea; Grisanti, Salvatore; Ripamonti, Carla Ida; Berruti, Alfredo; Piazza, Cesare; Bossi, Paolo
肿瘤
毒理研究
肿瘤免疫
头颈癌
发表日期：2025
文献求助 收藏

Timely, Cheap, or Risk-Free? The Effect of Regulation on the Price and Availability of New Drugs

及时、廉价还是无风险？监管对新药价格和可及性的影响

期刊:
影响因子:
doi:10.3390/pharmacy12020050
Levaggi, Laura; Levaggi, Rosella
发表日期：2024
文献求助 收藏

PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology

PARP抑制剂治疗BRCA1/2相关晚期HER2阴性乳腺癌：意大利肿瘤内科学协会的荟萃分析和GRADE推荐意见

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2022.10.014
Miglietta, Federica; Cinquini, Michela; Dieci, Maria Vittoria; Cortesi, Laura; Criscitiello, Carmen; Montemurro, Filippo; Del Mastro, Lucia; Zambelli, Alberto; Biganzoli, Laura; Levaggi, Alessia; Delle Piane, Chiara; Marchiò, Caterina; Calabrese, Massimo; Fortunato, Lucio; Franco, Pierfrancesco; Meduri, Bruno; Fittipaldo, Veronica Andrea; Gori, Stefania
肿瘤
HER2
肿瘤免疫
乳腺癌
BRCA1
PARP
发表日期：2022
文献求助 收藏

Less is more: an ecological and economic point of view on appropriate use of lab testing for COVID-19 patients

少即是多：从生态和经济角度探讨新冠肺炎患者实验室检测的合理使用

期刊:Bioanalysis
影响因子:1.8
doi:10.4155/bio-2021-0064
Signorini, Simona Giulia; Brugnoni, Duilio; Levaggi, Rosella; Garrafa, Emirena
肺炎
新冠
微生物学
发表日期：2021
文献求助 收藏

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study

早期乳腺癌患者剂量密集型辅助化疗：Mammella InterGruppo (MIG)-1 III 期研究的 15 年结果

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-020-0816-8
Blondeaux, Eva; Lambertini, Matteo; Michelotti, Andrea; Conte, Benedetta; Benasso, Marco; Dellepiane, Chiara; Bighin, Claudia; Pastorino, Simona; Levaggi, Alessia; Alonzo, Alessia D'; Poggio, Francesca; Buzzatti, Giulia; Molinelli, Chiara; Fregatti, Piero; Bertoglio, Sergio; Boccardo, Francesco; Del Mastro, Lucia
肿瘤
MIG
乳腺癌
肿瘤免疫
发表日期：2020
文献求助 收藏

Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer

绝经前早期乳腺癌患者辅助全身治疗的最新进展

期刊:Clinical Medicine Insights-Oncology
影响因子:1.9
doi:10.1177/1179554920931816
Parisi, Francesca; Razeti, Maria Grazia; Blondeaux, Eva; Arecco, Luca; Perachino, Marta; Tagliamento, Marco; Levaggi, Alessia; Fregatti, Piero; Poggio, Francesca; Lambertini, Matteo
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience

2019冠状病毒病疫情期间的实验室考量：布雷西亚Spedali Civili医院的经验

期刊:Bioanalysis
影响因子:1.8
doi:10.4155/bio-2020-0109
Garrafa, Emirena; Brugnoni, Duilio; Barbaro, Mosè; Andreoli, Laura; Focà, Emanuele; Salvetti, Massimo; Castelli, Francesco; Franceschini, Franco; Piva, Simone; Muiesan, Maria Lorenza; Latronico, Nicola; Levaggi, Rosella
微生物学
发表日期：2020
文献求助 收藏

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)

意大利肿瘤内科学会 (AIOM) 制定 GRADE（推荐等级、评估、制定和评价）建议，将铂类药物纳入三阴性乳腺癌患者的新辅助化疗方案中。

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers11081137
Dieci, Maria Vittoria; Del Mastro, Lucia; Cinquini, Michela; Montemurro, Filippo; Biganzoli, Laura; Cortesi, Laura; Zambelli, Alberto; Criscitiello, Carmen; Levaggi, Alessia; Conte, Benedetta; Calabrese, Massimo; Fiorentino, Alba; Marchiò, Caterina; Tinterri, Corrado; Fittipaldo, Veronica Andrea; Pappagallo, Giovanni; Gori, Stefania
肿瘤
肿瘤免疫
乳腺癌
发表日期：2019
文献求助 收藏

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study

激素治疗后序贯化疗或反序化疗作为激素敏感型、人表皮生长因子受体2阴性转移性乳腺癌患者的一线治疗：一项观察性研究的结果

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.14735
Bighin, Claudia; Dozin, Beatrice; Poggio, Francesca; Ceppi, Marcello; Bruzzi, Paolo; D'Alonzo, Alessia; Levaggi, Alessia; Giraudi, Sara; Lambertini, Matteo; Miglietta, Loredana; Vaglica, Marina; Fontana, Vincenzo; Iacono, Giuseppina; Pronzato, Paolo; Del Mastro, Lucia
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2017
文献求助 收藏